Navigation Links
Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program
Date:12/1/2009

REDONDO BEACH, Calif., Dec. 1 /PRNewswire/ -- Reproductive Partners Medical Group, Inc. announces their Elective Single Embryo Transfer (eSET) Encouragement Program to provide a financial incentive for patients with good embryo quality and a good prognosis for success to consider reducing the chance of twins by transferring a single embryo.

The biggest issue in advanced reproductive technology today is reducing the number of multiple pregnancies, even twin pregnancies. In the early days of in vitro fertilization, it was common to transfer a large number of embryos to try to achieve a healthy pregnancy. Today, fewer embryos are required to attain a reasonable chance of success.

"Couples with fertility problems often assume that they can double their chances for a healthy baby by transferring two embryos instead of just one," explains Dr. Wisot. "But data recently published in the New England Journal of Medicine shows that what they're really doing is increasing their odds of having twins, which is riskier for the mother and babies alike."

Pregnancies involving multiples, including twins, come with a greater risk of gestational diabetes, bleeding and preeclampsia for the mother, and cerebral palsy, birth defects, developmental delays and death for the babies. Twins usually survive, but incur higher medical expenses in the first five years of life.

Despite the risks involved in transferring multiple embryos, couples must weigh this decision against both the chance of a failed cycle and the costs incurred by starting another fresh or frozen embryo cycle.

For patients who qualify, the eSET Encouragement Program reduces the economic rationale for transferring more than one embryo. If an elective single embryo transfer is recommended and accepted by the couple and they do not achieve a 12-week pregnancy, the fees for embryo freezing and six months of storage will be waived.

"This innovative program incentivizes IVF patients to avoid the dangers of a twin pregnancy," says Dr. Wisot. "If Octo-Mom represents the dark side of reproductive medicine, the eSET Encouragement Program is the light."

For more information on the Reproductive Partners - Medical Group, Inc. Elective Single Embryo Transfer (eSET) Encouragement Program, please contact Dr. Arthur Wisot or visit http://www.reproductivepartners.com.

SOURCE Reproductive Partners Medical Group


'/>"/>
SOURCE Reproductive Partners Medical Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
3. Reproductive Partners Participates in New IVF Progesterone Delivery System Study
4. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
5. Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
10. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
11. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ORLANDO, Fla. , Feb. 18, 2017 /PRNewswire/ ... announced that positive Phase 1 clinical data for Nektar,s ... carcinoma (RCC) were presented at ASCO GU 2017.  NKTR-214 ... cancer-fighting T cells and Natural Killer (NK) cell abundance ... PD-1 on these immune cells.  The results were presented ...
(Date:2/17/2017)... Feb. 17, 2017  Ethicon, Inc. today announced ... a privately held medical device company that manufactures ... System, a novel minimally invasive device for the ... Medical will enable Ethicon to offer patients a ... Nissen fundoplication surgical procedure. 1 ...
(Date:2/17/2017)... and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing ... ... the US, Canada , Japan , ... of World. Annual estimates and forecasts are provided for the period 2015 ... Market data and analytics are derived from primary and secondary research. ...
Breaking Medicine Technology:
(Date:2/18/2017)... , ... February 18, 2017 , ... ... provides the latest information and contact points to easily connect elderly veterans of ... assisted living, and elder-care funding. It also conveys material on this year's increase ...
(Date:2/17/2017)... ... 17, 2017 , ... For the first time, International Scholarship ... exhibit floor for the 2017 HIMSS Conference & Exhibition at the ... more than 40,000 healthcare industry professionals are expected at the conference, where they ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth ... most widely used electronic patient signatures solution in healthcare . , Since ...
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... premier sponsor and exhibitor at Molecular Medicine Tri-Conference February 20 – 22 in ... Wednesday, Inspirata will showcase its anatomic and molecular pathology workflow solution, as well ...
(Date:2/16/2017)... York, New York (PRWEB) , ... February 17, ... ... work and determination. After what took over 10 years of research, development and ... technology, NTX Technology™. NTX Technology™ is a patented compound of FDA approved ingredients ...
Breaking Medicine News(10 mins):